Fanlu Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
- Oncology 5
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Ubiquitin and proteasome pathways 2
- Co-authors
- Baiyong Shen (7 shared papers)Siyi Zou (6 shared papers)Yizhi Cao (3 shared papers)Chenlei Wen (5 shared papers)Pengyi Liu (2 shared papers)Zhiwei Xu (2 shared papers)Minmin Shi (2 shared papers)Qian Zhan (1 shared paper)
- Journals
- Cancer Letters (1 paper)Journal of Hematology & Oncology (1 paper)Journal of Clinical Oncology (1 paper)Frontiers in Oncology (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited KingdomAustralia
In The Last Decade
Fanlu Li
13 papers receiving 277 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 115
- Molecular Biology 164
- Immunology 45
- Oncology 50
- Hepatology 11
Countries citing papers authored by Fanlu Li
This map shows the geographic impact of Fanlu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanlu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanlu Li more than expected).
Fields of papers citing papers by Fanlu Li
This network shows the impact of papers produced by Fanlu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanlu Li. The network helps show where Fanlu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanlu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 121 | |
| 2 | 2022 | 32 | |
| 3 | 2023 | 28 | |
| 4 | 2016 | 24 | |
| 5 | 2020 | 22 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 9 | |
| 9 | 2024 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2024 | 2 | |
| 13 | 2025 | 2 |
About Fanlu Li
Fanlu Li is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Epidemiology, having authored 13 papers that have together received 280 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ubiquitin and proteasome pathways (2 papers), Immune cells in cancer (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Cancer Genomics and Diagnostics (1 paper), Immunotherapy and Immune Responses (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Cancer Research (115 citations), Molecular Biology (164 citations), Immunology (45 citations), Oncology (50 citations) and Hepatology (11 citations). Fanlu Li has collaborated with scholars based in China, United Kingdom and Australia. Frequent co-authors include Baiyong Shen, Siyi Zou, Yizhi Cao, Chenlei Wen, Pengyi Liu, Zhiwei Xu, Minmin Shi, Qian Zhan, Jiancheng Wang and Xingfeng He. Their work appears in journals such as Cancer Letters, Journal of Hematology & Oncology, Journal of Clinical Oncology, Frontiers in Oncology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.